List of bibliographic references
Number of relevant bibliographic references: 6.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 3 | Aged |
| 3 | Elderly |
| 3 | Humans |
| 2 | Female |
| 2 | Geriatrics |
| 2 | Gerontology |
| 2 | Male |
| 2 | Middle Aged |
| 2 | Psychotropic |
| 2 | Serotonin Uptake Inhibitors (adverse effects) |
| 2 | Serotonin Uptake Inhibitors (therapeutic use) |
| 1 | Abortifacient |
| 1 | Accidental Falls (prevention & control) |
| 1 | Age of Onset |
| 1 | Aged, 80 and over |
| 1 | Antidepressant agent |
| 1 | Antidepressive Agents (adverse effects) |
| 1 | Antidepressive Agents (therapeutic use) |
| 1 | Antineoplastic agent |
| 1 | Anxiety |
| 1 | Anxiety Disorders (drug therapy) |
| 1 | Anxiety Disorders (genetics) |
| 1 | Anxiety disorder |
| 1 | Aripiprazole |
| 1 | Bone |
| 1 | Citalopram (adverse effects) |
| 1 | Citalopram (blood) |
| 1 | Citalopram (therapeutic use) |
| 1 | Cognition |
| 1 | Cognitive disorder |
| 1 | Concomitant disease |
| 1 | Cyclohexanols (administration & dosage) |
| 1 | Cyclohexanols (therapeutic use) |
| 1 | Delayed-Action Preparations |
| 1 | Depression |
| 1 | Depression (drug therapy) |
| 1 | Depressive Disorder, Major (drug therapy) |
| 1 | Depressive Disorder, Major (epidemiology) |
| 1 | Diseases of the osteoarticular system |
| 1 | Double-Blind Method |
| 1 | Drug Therapy, Combination |
| 1 | Escitalopram |
| 1 | Follow up study |
| 1 | Generalized anxiety disorder |
| 1 | Genotype |
| 1 | Glucocorticoid |
| 1 | Health |
| 1 | Inappropriate Prescribing |
| 1 | Logistic Models |
| 1 | Memory |
| 1 | Mental health |
| 1 | Mifepristone |
| 1 | Neuropsychological test |
| 1 | Observational Studies as Topic |
| 1 | Pharmacotherapy |
| 1 | Piperazines (therapeutic use) |
| 1 | Polymorphism, Genetic |
| 1 | Predictive Value of Tests |
| 1 | Promoter Regions, Genetic (genetics) |
| 1 | Psychiatric Status Rating Scales (statistics & numerical data) |
| 1 | Psychiatry |
| 1 | Psychology |
| 1 | Public health |
| 1 | Quinolones (therapeutic use) |
| 1 | Randomized Controlled Trials as Topic |
| 1 | Receptor, Serotonin, 5-HT1A (genetics) |
| 1 | Receptor, Serotonin, 5-HT2A (genetics) |
| 1 | Remission Induction |
| 1 | Result |
| 1 | Serotonin Plasma Membrane Transport Proteins (genetics) |
| 1 | Serotonin Uptake Inhibitors (blood) |
| 1 | Severity of Illness Index |
| 1 | Signal Detection, Psychological |
| 1 | Social environment |
| 1 | Stress |
| 1 | Symptom Assessment (statistics & numerical data) |
| 1 | Systematic review |
| 1 | Therapeutic role |
| 1 | Tranquillizer |
| 1 | Treatment |
| 1 | Treatment Outcome |
| 1 | United States |
| 1 | Venlafaxine Hydrochloride |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Eric J. Lenze"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "Eric J. Lenze" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Eric J. Lenze
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021 |  |
